YUDEMSA Trademark

Trademark Overview

On Wednesday, November 3, 2021, a trademark application was filed for YUDEMSA with the United States Patent and Trademark Office. The USPTO has given the YUDEMSA trademark a serial number of 97107192. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by Principia Biopharma Inc.. The YUDEMSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
yudemsa

General Information

Serial Number97107192
Word MarkYUDEMSA
Filing DateWednesday, November 3, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrincipia Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NamePrincipia Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Saturday, November 6, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 9, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 17, 2021ASSIGNED TO LIE
Tuesday, April 12, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 17, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, March 11, 2022ASSIGNED TO EXAMINER
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 12, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 21, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 21, 2022SOU EXTENSION 1 FILED
Friday, October 21, 2022SOU EXTENSION 1 GRANTED
Tuesday, October 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 24, 2023SOU EXTENSION 2 FILED
Monday, April 24, 2023SOU EXTENSION 2 GRANTED
Thursday, November 9, 2023SOU EXTENSION 3 FILED
Thursday, November 9, 2023SOU EXTENSION 3 GRANTED
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

yudemsa pharmaceutical preparations diseases preventing disorders treating blood tumors lesions skin